IPRC
ALXN

Indices-Pac Research Corporation’s Alexion Pharmaceuticals ALXN Stock Holding History

Indices-Pac Research Corporation’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,497
Closed -$639K – 251
2013
Q3 		$639K Buy
+5,497
New +$603K 0.42% 80

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Indices-Pac Research Corporation's ALXN Position: Q4 2013 in Review

Indices-Pac Research Corporation sold out of Alexion Pharmaceuticals (ALXN) in Q4 2013, closing a stake of 5,497 shares — an estimated $639K sold.

Indices-Pac Research Corporation first reported a position in ALXN in Q3 2013 and held it in 1 quarter. The position peaked at $639K in Q3 2013. 462 funds tracked by Wall St. Rank hold ALXN as of Q4 2013.

  • Indices-Pac Research Corporation reported no remaining Alexion Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Indices-Pac Research Corporation sold 5,497 Alexion Pharmaceuticals shares in Q4 2013, an estimated $639K.
  • Indices-Pac Research Corporation first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • Indices-Pac Research Corporation's Alexion Pharmaceuticals position peaked at $639K in Q3 2013.
  • 462 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2013.

Based on Indices-Pac Research Corporation's 13F filing for Q4 2013, filed 14 Feb 2014.